195 results
-
List item
Orphan designation: Refusal of orphan designation for the treatment of retinopathy of prematurity
Date of refusal of designation: 28/11/2022, Negative, Last updated: 23/01/202328/11/2022 Industria Farmaceutica Galenica Senese S.r.l. Via Cassia Nord 351 … -
List item
National expert: Alessandra Renieri, European Medicines Agency (updated)
- Declaration of interests - 81.62 KB | PDF
- Curriculum Vitae - 25.69 KB | PDF
Ospedaliera Universitaria Senese (Italy) 1998- 2000 Researcher … Ospedaliera Universitaria Senese (Italy) 2007- Present Full … Azienda Ospedaliera Universitaria Senese (AOUS) of 5 European Reference … -
List item
National expert: Jesus Chesa Jimenez, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 79.82 KB | PDF
- Curriculum Vitae - 21.93 KB | PDF
-
List item
National expert: Jeanette Birgitta Johansson, Medical Products Agency (updated)
- Declaration of interests - 80.77 KB | PDF
- Curriculum Vitae - 18.63 KB | PDF
for Karo Pharma AB and Galenica Cross product responsibility … -
List item
National expert: Christoph Mueck, Austrian Medicines and Medical Devices Agency (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 20.07 KB | PDF
secreted proteins involved in senescence of human endothelial cells … interactions in UVB-induced senescence of human diploid fibroblasts." BMC … binding protein-6 de-lays replicative senescence of human fibroblasts" Mechanisms … -
List item
National expert: Pia Rivetti di Val Cervo, Italian Medicines Agency (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 23.34 KB | PDF
epidermal differentiation and senescence, as well as brain morphogenesis. September … Candi E."MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation." 06/02/2023 … feedback in keratinocyte senescence." Proc Natl Acad Sci USA … -
List item
National expert: Juan Fernando Martínez Leal, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 80.37 KB | PDF
- Curriculum Vitae - 26.27 KB | PDF
-
List item
National expert: Christophe Richez, European Medicines Agency (updated)
- Declaration of interests - 93.37 KB | PDF
- Curriculum Vitae - 19.21 KB | PDF
Barnetche T, Duffau P, Couzi L, Seneschal J, Blanco P, Lazaro E, Richez … Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL … Barnetche T, Blanco P, Lazaro E, Seneschal J, Truchetet ME, Duffau P … -
List item
National expert: Federica Chiara, European Medicines Agency (updated)
- Declaration of interests - 80.35 KB | PDF
- Curriculum Vitae - 34.44 KB | PDF
Italy) Molecular mechanisms of Neuronal Senescence. Proteomic, Molecular Oncology … -
List item
National expert: Fernando Blanco, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 79.97 KB | PDF
- Curriculum Vitae - 19 KB | PDF
et al. "Exploring cellular senescence as a tumor suppressor mechanism".Rev … MV and Romero L. Cellular Senescence and Cancer. Res. Adv. Cancer … -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 15, Authorised, Last updated: 20/02/2023 -
List item
Human medicine European public assessment report (EPAR): Spherox (updated)
spheroids of human autologous matrix-associated chondrocytes, Cartilage Diseases
Date of authorisation: 10/07/2017, Revision: 8, Authorised, Last updated: 20/02/2023 -
List item
Human medicine European public assessment report (EPAR): Verzenios (updated)
abemaciclib, Breast Neoplasms
Date of authorisation: 26/09/2018,
, Revision: 9, Authorised, Last updated: 22/02/2023
-
List item
Human medicine European public assessment report (EPAR): Adasuve
loxapine, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/02/2013, Revision: 14, Authorised, Last updated: 14/11/2022 -
List item
Human medicine European public assessment report (EPAR): Ibrance
palbociclib, Breast Neoplasms
Date of authorisation: 09/11/2016,, Revision: 14, Authorised, Last updated: 26/10/2022
-
List item
Human medicine European public assessment report (EPAR): Ameluz
5-aminolevulinic acid hydrochloride, Keratosis, Actinic; Carcinoma, Basal Cell
Date of authorisation: 13/12/2011, Revision: 19, Authorised, Last updated: 23/03/2022 -
List item
Human medicine European public assessment report (EPAR): Jorveza
budesonide, Esophageal Diseases
Date of authorisation: 08/01/2018,
, 
, Revision: 6, Authorised, Last updated: 06/12/2022
-
List item
Human medicine European public assessment report (EPAR): Cuprior (updated)
Trientine tetrahydrochloride, Hepatolenticular Degeneration
Date of authorisation: 05/09/2017, Revision: 6, Authorised, Last updated: 20/02/2023 -
List item
National expert: Raquel Martin Palomeque, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 79.82 KB | PDF
- Curriculum Vitae - 22.04 KB | PDF
defence-related genes during senescence: a correlation between gene … -
List item
Human medicine European public assessment report (EPAR): Skilarence
dimethyl fumarate, Psoriasis
Date of authorisation: 23/06/2017, Revision: 11, Authorised, Last updated: 27/09/2022 -
List item
Human medicine European public assessment report (EPAR): Feraccru
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 17, Authorised, Last updated: 12/12/2022 -
List item
Human medicine European public assessment report (EPAR): Pyrukynd
mitapivat sulfate, Genetic Diseases, Inborn; Anemia, Hemolytic
Date of authorisation: 09/11/2022,, , Authorised, Last updated: 05/12/2022
-
List item
Human medicine European public assessment report (EPAR): Episalvan
Betulae cortex, Wounds and Injuries; Wound Healing
Date of authorisation: 14/01/2016, Revision: 7, Withdrawn, Last updated: 15/07/2022 -
List item
Human medicine European public assessment report (EPAR): Opsumit
Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013,, Revision: 21, Authorised, Last updated: 22/12/2022
-
List item
National expert: Dieter Pullirsch, Austrian Medicines and Medical Devices Agency (updated)
- Declaration of interests - 79.79 KB | PDF
- Curriculum Vitae - 16.95 KB | PDF
France) Research: cellular senescence EDUCATION AND TRAINING February …